White House ignoring, unlikely to approve FDA's new COVID-19 vaccine guidelines

The FDA's new COVID-19 vaccine approval guidelines have been stalled by the White House and are unlikely to gain approval from the president, according to an Oct. 5 report from The New York Times.

The agency sent its guidelines to the Office of Management and Budget for approval around mid-September, and they have stalled in the office of White House Chief of Staff Mark Meadows, according to the newspaper.